On ECHEMI
Home > Drugs > Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
  • Founded in:

    1998-12-04
  • Country:

    China China
  • Address:

    No. 11, Haiying Road, Science and Technology Park, Fengtai District, Beijing [Park]
  • Tax NO.:

    91110106700101574K
  • Registered Funds:

    150 million yuan
  • Website:

  • Email:

Related Drugs
Ethylenediamine diacetate for injection
Ethylenediamine diacetate.
Name Description Content CAS NO. Registered Holders
Clotrimazole

1. Inhibit plasminogen activators, so that plasminogen cannot be activated into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect; 2. Promote the release of active substances by platelets, enhance platelet aggregation and adhesion, shorten coagulation time, and produce a hemostatic effect; 3. Enhance capillary resistance, reduce capillary permeability, and thus reduce bleeding.

More

1. Inhibit plasminogen activators, so that plasminogen cannot be activated into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect; 2. Promote the release of active substances by platelets, enhance platelet aggregation and adhesion, shorten coagulation time, and produce a hemostatic effect; 3. Enhance capillary resistance, reduce capillary permeability, and thus reduce bleeding.

0
Ethylenediamine diacetate for injection
Ethylenediamine diacetate.
Name Description Content CAS NO. Registered Holders
Clotrimazole

1. Inhibit plasminogen activators, so that plasminogen cannot be activated into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect; 2. Promote the release of active substances by platelets, enhance platelet aggregation and adhesion, shorten coagulation time, and produce a hemostatic effect; 3. Enhance capillary resistance, reduce capillary permeability, and thus reduce bleeding.

More

1. Inhibit plasminogen activators, so that plasminogen cannot be activated into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect; 2. Promote the release of active substances by platelets, enhance platelet aggregation and adhesion, shorten coagulation time, and produce a hemostatic effect; 3. Enhance capillary resistance, reduce capillary permeability, and thus reduce bleeding.

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.